Destination Therapy Post Approval Study Product Surveillance Registry Platform Addendum and Apogee
Enrolling By Invitation
99 years and younger
All
Phase
N/A
3 participants needed
1 Location
Brief description of study
The purpose of DT PAS PSR is to
-Provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products for their intended use
-To further confirm safety and effectiveness of the HVAD System when used as intended for DT, in real-world clinical practice
The purpose of Apogee optional sub-study is to further enhance scientific understanding of the implant procedure, optimize blood pressure management, and anticoagulation/antiplatelet therapies.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Heart Failure
-
Age: - 99 Years
-
Gender: All
Prior Destiantion Therapy
Updated on
22 Aug 2024.
Study ID: 832738
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
